These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2446008)

  • 41. Cytotoxic T lymphocytes and neutralizing antibody in the control of equine infectious anemia virus.
    McGuire TC; Fraser DG; Mealey RH
    Viral Immunol; 2002; 15(4):521-31. PubMed ID: 12513924
    [No Abstract]   [Full Text] [Related]  

  • 42. High prevalence of serum antibodies to equine infectious anemia virus reverse transcriptase.
    DeVico AL; Issel CJ; Le Grice SF; Payne SL; Montelaro RC; Sarngadharan MG
    AIDS Res Hum Retroviruses; 1993 Jan; 9(1):7-11. PubMed ID: 7678974
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Equine infectious anaemia virus proteins with epitopes most frequently recognized by cytotoxic T lymphocytes from infected horses.
    McGuire TC; Leib SR; Lonning SM; Zhang W; Byrne KM; Mealey RH
    J Gen Virol; 2000 Nov; 81(Pt 11):2735-2739. PubMed ID: 11038386
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication.
    Craigo JK; Leroux C; Howe L; Steckbeck JD; Cook SJ; Issel CJ; Montelaro RC
    J Gen Virol; 2002 Jun; 83(Pt 6):1353-1359. PubMed ID: 12029150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transient suppression of equine immune responses by equine infectious anemia virus (EIAV).
    Newman MJ; Issel CJ; Truax RE; Powell MD; Horohov DW; Montelaro RC
    Virology; 1991 Sep; 184(1):55-66. PubMed ID: 1651604
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Control of equine infectious anemia virus is not dependent on ADCC mediating antibodies.
    Tschetter JR; Byrne KM; Perryman LE; McGuire TC
    Virology; 1997 Apr; 230(2):275-80. PubMed ID: 9143283
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Equine infectious anemia virus: immunopathogenesis and persistence.
    Cheevers WP; McGuire TC
    Rev Infect Dis; 1985; 7(1):83-8. PubMed ID: 2984759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Specificity of response to viral proteins in horses infected with equine infectious anemia virus.
    Charman H; Long C; Coggins L
    Infect Immun; 1979 Feb; 23(2):472-8. PubMed ID: 217831
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation of hemagglutinating antigen of equine infectious anemia virus from infected equine leukocyte cultures.
    Sentsui H; Kono Y
    Natl Inst Anim Health Q (Tokyo); 1978; 18(1):39-40. PubMed ID: 206841
    [No Abstract]   [Full Text] [Related]  

  • 50. Equine infectious anemia virus derived from a molecular clone persistently infects horses.
    Whetter L; Archambault D; Perry S; Gazit A; Coggins L; Yaniv A; Clabough D; Dahlberg J; Fuller F; Tronick S
    J Virol; 1990 Dec; 64(12):5750-6. PubMed ID: 2173767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies.
    Leroux C; Craigo JK; Issel CJ; Montelaro RC
    J Virol; 2001 May; 75(10):4570-83. PubMed ID: 11312327
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preparation of equine infectious anemia antigens for diagnosis.
    Ueda S; Samejima T; Kuroda S; Nakamura J
    Jpn J Microbiol; 1973 Sep; 17(5):393-9. PubMed ID: 4128832
    [No Abstract]   [Full Text] [Related]  

  • 53. Cytotoxic T lymphocytes in protection against equine infectious anemia virus.
    McGuire TC; Fraser DG; Mealey RH
    Anim Health Res Rev; 2004 Dec; 5(2):271-6. PubMed ID: 15984338
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Course and extent of variation of equine infectious anemia virus during parallel persistent infections.
    Payne SL; Salinovich O; Nauman SM; Issel CJ; Montelaro RC
    J Virol; 1987 Apr; 61(4):1266-70. PubMed ID: 3029423
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antigenic mapping of the envelope proteins of equine infectious anemia virus: identification of a neutralization domain and a conserved region on glycoprotein 90.
    Hussain KA; Issel CJ; Schnorr KL; Rwambo PM; West M; Montelaro RC
    Arch Virol; 1988; 98(3-4):213-24. PubMed ID: 2450529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Leukocyte cytotoxicity in a persistent virus infection: presence of direct cytotoxicity but absence of antibody-dependent cellular cytotoxicity in horses infected with equine infectious anemia virus.
    Fujimiya Y; Perryman LE; Crawford TB
    Infect Immun; 1979 Jun; 24(3):628-36. PubMed ID: 223981
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Equine infectious anemia.
    Sellon DC
    Vet Clin North Am Equine Pract; 1993 Aug; 9(2):321-36. PubMed ID: 8395326
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic variation of envelope gp90 gene of equine infectious anemia virus isolated from an experimentally infected horse.
    Pang H; Kong XG; Sentsui H; Kono Y; Sugiura T; Hasegawa A; Akashi H
    J Vet Med Sci; 1997 Dec; 59(12):1089-95. PubMed ID: 9450237
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genomic alterations associated with persistent infections by equine infectious anaemia virus, a retrovirus.
    Payne S; Parekh B; Montelaro RC; Issel CJ
    J Gen Virol; 1984 Aug; 65 ( Pt 8)():1395-9. PubMed ID: 6086822
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Viral DNA in horses infected with equine infectious anemia virus.
    Rice NR; Lequarre AS; Casey JW; Lahn S; Stephens RM; Edwards J
    J Virol; 1989 Dec; 63(12):5194-200. PubMed ID: 2555550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.